This suggests that diversity of tau folds is intrinsic to the pathogenesis of each form of tauopathy and that effective therapeutic interventions will need to address evolving repertoires of misfolded tau species rather than singular static molecular targets. This evidence concerns the gene MAPT and tauopathy.